E-LIB Suche - Ergebnisse für: Láng, István

1

Evaluating Science and Scientists:

Cave, Jane ; Cave, Jane ; Darvas, Gyorgy... , [2022]

Link: https://www.degruyter.co..

2

Niraparib for Advanced Breast Cancer with Germline BRCA1 an..:

Turner, Nicholas C. ; Balmaña, Judith ; Poncet, Coralie...
Clinical Cancer Research. 27 (2021) 20 - p. 5482-5491 , 2021

Link: https://doi.org/10.1158/..

3

Tumor Cellularity and Infiltrating Lymphocytes as a Surviva..:

Chic, Nuria ; Luen, Stephen J ; Nuciforo, Paolo...
JNCI: Journal of the National Cancer Institute. 114 (2021) 3 - p. 467-470 , 2021

Link: https://doi.org/10.1093/..

4

Health-related quality of life with palbociclib plus endocr..:

Kahan, Zsuzsanna ; Gil-Gil, Miguel ; Ruiz-Borrego, Manuel...
European Journal of Cancer. 156 (2021) - p. 70-82 , 2021

Link: https://doi.org/10.1016/..

5

Updated results from the international phase III ALTTO tria..:

Moreno-Aspitia, Alvaro ; Holmes, Eileen M. ; Jackisch, Christian...
European Journal of Cancer. 148 (2021) - p. 287-296 , 2021

Link: https://doi.org/10.1016/..

6

A phase 1, open-label, drug–drug interaction study of rucap..:

Liao, Mingxiang ; Jeziorski, Krzysztof G. ; Tomaszewska-Kiecana, Monika...
Cancer Chemotherapy and Pharmacology. 88 (2021) 5 - p. 887-897 , 2021

Link: https://doi.org/10.1007/..

7

Long-term cardiac outcomes of patients with HER2-positive b..:

Eiger, Daniel ; Pondé, Noam F. ; Agbor-Tarh, Dominique...
British Journal of Cancer. 122 (2020) 10 - p. 1453-1460 , 2020

Link: https://doi.org/10.1038/..

8

Clinical behavior of recurrent hormone receptor–positive br..:

Leone, Jose P. ; Cole, Bernard F. ; Regan, Meredith M....
Cancer. 127 (2020) 5 - p. 700-708 , 2020

Link: https://doi.org/10.1002/..

9

Cumulative incidence of cardiovascular events under tamoxif..:

Rabaglio, Manuela ; Sun, Zhuoxin ; Maibach, Rudolf...
Breast Cancer Research and Treatment. 185 (2020) 3 - p. 697-707 , 2020

Link: https://doi.org/10.1007/..

10

Potential Drug–Drug Interactions with Combination Volaserti..:

Lang, Istvan ; Liu, Dan ; Fritsch, Holger...
Clinical Therapeutics. 42 (2020) 11 - p. 2214-2224 , 2020

Link: https://doi.org/10.1016/..

11

Evaluation of the effect of P‐glycoprotein inhibition and i..:

Elmeliegy, Mohamed ; Láng, István ; Smolyarchuk, Elena A....
British Journal of Clinical Pharmacology. 86 (2020) 4 - p. 771-778 , 2020

Link: https://doi.org/10.1111/..

12

A comparison of eflapegrastim to pegfilgrastim in the manag..:

Cobb, Patrick Wayne ; Moon, Yong Wha ; Mezei, Klára...
Cancer Medicine. 9 (2020) 17 - p. 6234-6243 , 2020

Link: https://doi.org/10.1002/..

13

Randomized phase 3 efficacy and safety trial of proposed pe..:

Waller, Cornelius F. ; Ranganna, Gopinath M. ; Pennella, Eduardo J....
Annals of Hematology. 98 (2019) 5 - p. 1217-1224 , 2019

Link: https://doi.org/10.1007/..

14

Survival outcomes of the NeoALTTO study (BIG 1–06): updated..:

Huober, Jens ; Holmes, Eileen ; Baselga, José...
European Journal of Cancer. 118 (2019) - p. 169-177 , 2019

Link: https://doi.org/10.1016/..

15

Mutational analysis of triple-negative breast cancers withi..:

Munzone, Elisabetta ; Gray, Kathryn P. ; Fumagalli, Caterina...
Breast Cancer Research and Treatment. 170 (2018) 2 - p. 351-360 , 2018

Link: https://doi.org/10.1007/..